Automated Breast Ultrasound System (ABUS) Market is Expected to Grow with a CAGR of 15.9% from 2022 to 2028

Automated Breast Ultrasound System (ABUS)
  • Automated Breast Ultrasound System (ABUS) Market

As stated in our extensive report, providing insights on Product, Application, and End-user; theGlobalAutomated Breast Ultrasound System (ABUS) Marketaccounted forUSD 705.5 Millionin 2021.

The most common form of cancer found in women is breast cancer. It has spread worldwide and is a serious health concern as it is the major type of cancer found in the female population. In order to reduce the morbidity & mortality rates and increase survival chances, healthcare providers focus on its early detection. Well-established technologies such as Mammography and ultrasound are used for screening and early detection of breast cancer. Mammography technology has presented promising results in the detection of tumors in women with the help of ultrasound techniques.

Automated Breast Ultrasound System (ABUS) is a recent technology developed in the field of ultrasound imaging that is developed to obtain an operator-independent system. Automated Breast Ultrasound System (ABUS) is a reproducible system and obtains high resolution through three-dimensional imaging. This system contributes to handling comfort, accuracy, and time-efficiency in various research activities. The Automated Breast Ultrasound System (ABUS) provides high features in cancer detection by providing detection rate, image quality, higher sensitivity, and diagnostic accuracy rates. Recent advancements in Automated Breast Ultrasound System (ABUS) systems help higher-frequency transducers to facilitate the reproduction of superior quality images within a short time period. All these parameters are responsible for augmenting the growth of Automated Breast Ultrasound System (ABUS) Market in upcoming years.

Increasing breast cancer prevalence & incidences, growing awareness of patients toward the connection of breast density, and rising radiology demand for treating breast cancer are fuelling the growth of Automated Breast Ultrasound System (ABUS) Market from past few years. In addition, increasing government support towards spreading breast cancer awareness should further enhance the industry demand. Technological improvements for using upgraded imaging techniques along with heavy investments provide effective growth in the market. Benefits provided by the automated breast ultrasound system include 3D imaging, coronal view, high-quality imaging, and rapid results with the assurance of improved diagnostic. These benefits are augmenting the growth of Automated Breast Ultrasound System (ABUS) Market in the coming years. Furthermore, rising cases of breast cancer every year, especially in the female population, and rising healthcare expenditures will provide various growth opportunities for Automated Breast Ultrasound System (ABUS) Market in the near future. The major reasons for the growth of breast cancer in women are reduced childbearing, age-related risks, obesity, and hormonal imbalance.

North America is accounted to mention the largest growth of Automated Breast Ultrasound System (ABUS) market during the forecast period. Factors such as rising healthcare expenditure, availability of several key players, and increasing prevalence of breast cancer in the U.S. are propelling the growth of the Automated Breast Ultrasound System (ABUS) Market in this region. In addition, various market players are started investing in the strategic development of the market, which, in turn, influences the growth of Automated Breast Ultrasound System (ABUS) Market in this region. For instance, GE Healthcare, a leading global medical technology, collaborated with Premier Inc., an American healthcare improvement company, to develop a model to bring a same-day breast cancer diagnosis and treatment model to the U.S.

Some of the prominent players operating in the Global Automated Breast Ultrasound System (ABUS) Market areGE Healthcare (US), Siemens AG (Germany), Koninklijke Philips N.V. (Netherlands), Hitachi Ltd. (Japan), and SonoCine Inc. (US)..